Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

Clinical Utility of Pharmacogenetic Testing in Compounding Pharmacy

Author(s):  Fichter Brian, Heintzelman Tom, Hurst Sawan, Fitzsimmons Dorothy, Mailloux Christina

Issue:  Nov/Dec 2013 - Volume 17, Number 6
View All Articles in Issue

Page(s):  452-457

Clinical Utility of Pharmacogenetic Testing in Compounding Pharmacy Page 1
Clinical Utility of Pharmacogenetic Testing in Compounding Pharmacy Page 2
Clinical Utility of Pharmacogenetic Testing in Compounding Pharmacy Page 3
Clinical Utility of Pharmacogenetic Testing in Compounding Pharmacy Page 4
Clinical Utility of Pharmacogenetic Testing in Compounding Pharmacy Page 5
Clinical Utility of Pharmacogenetic Testing in Compounding Pharmacy Page 6

Download in electronic PDF format for $65

Abstract:  Pharmacists must consider all factors when dosing medication for a patient. Until recently, however, one key piece to this puzzle was missing—genetics. This invisible piece of the puzzle can now be utilized with pharmacogenetic testing. By using pharmacogenetic testing, the compounding pharmacist will be able to better predict disease risk as well as the pharmacodynamic and pharmacokinetic actions of the prescriptions their patients are taking. Pharmacogenetics is poised to become the standard of care that not only physicians are embracing, but pharmacists can utilize to better personalize their patient’s needs.

Related Keywords: Brian Fichter, PharmD, Tom Heintzelman, PhD, Sawan Hurst, MS, Dorothy Fitzsimmons, RN, Christina Mailloux, PhD, pharmacogenetics, genetics, genetic testing, personalize, personalization, metabolic pathways, response to therapy, breast cancer risk prediction, hormone replacement therapy, HRT, cytochrome P450, warfarin, gene mutations, single nucleotide polymorphisms

Related Categories: HRT, ENDOCRINOLOGY/HORMONES/ MENOPAUSE/ANDROPAUSE, PATIENT ASSESSMENT

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Clinical Utility of Pharmacogenetic Testing in Compounding Pharmacy
Fichter Brian
, Heintzelman Tom, Hurst Sawan, Fitzsimmons Dorothy, Mailloux Christina
Nov/Dec 2013
Pg. 452-457

Bioidentical Hormone Replacement Therapy, Part 3, A Review of
Wepfer Scott T
Mar/Apr 2002
Pg. 142-146

The Science Behind Hormone Replacement Therapy, Part 1
Wepfer Scott T
Nov/Dec 2001
Pg. 462-464

Impact of Conventional and Bioidentical Hormone Replacement Therapy on Cardiovascular and Breast Health: A Review
Ruiz Andres D
, Daniels Kelly R, Barner Jamie C, Carson John J, Frei Christopher R
Jul/Aug 2011
Pg. 290-300

Using Serum Hormone Analysis to Develop Hormone Replacement Therapy Regimens-Part 1
Ford Gina
, Garcia Lea
Nov/Dec 2000
Pg. 421-422

The Value of Hormone Assessment
Collins Joseph J
Sep/Oct 2001
Pg. 342-344

Poster Presentation Report: Safety of Maternal Testosterone Therapy During Breast Feeding
Glaser Rebecca L
, Newman Mark, Parsons Melanie, Zava David, Glaser-Garbrick Daniel
Jul/Aug 2009
Pg. 314-317

Saliva Tests, Part 2: Salivary Hormones, Hormone Replacement Pharmacokinetics, and the Importance of Timely Testing
Kells John
, Dollbaum Charles M
Sep/Oct 2009
Pg. 392-399

A Perspective on HRT for Women: Picking Up the Pieces After the Women's Health Initiative Trial - Part 1
Gillson George R
, Zava David T
Jul/Aug 2003
Pg. 250-256

Hormone Therapy: It's Time for a Second Opinion
Collins Joseph J
, Ahlgrimm Maria
Mar/Apr 2008
Pg. 122-127